To improve the quality of magnetic resonance (MR) angiography, various performance enhancing MR sequences and scanning protocols have been adopted (1 7). The development of higher performance MR scanners has facilitated these trials (5, 8, 9) , and contrast-enhanced MR angiography (CEMRA) has thus become a feasible method of vascular imaging. Various amounts of contrast media have been used for CEMRA, ranging from the standard dose of 0.05 mmol / kg to 60 mL per patient (2, 5, 8, 10 14). High-dose CEMRA was generally believed to allow a higher signal-to-noise ratio and easier scanning, though its cost-effectiveness and safety issues were questionable (11). Currently, the preferred amount of contrast medium is that of the standard dose, on the basis of bolus injection, although double or triple dose contrast continues to be used in cases involving prolonged acquisition (7, 11 13). While involved in work to optimize the amount of contrast medium used for routine CEMRA, we examined the usage of dosages lower than those normally employed. In this study we evaluated the effectiveness of low-dose CEMRA by comparing it with conventional digital subtraction angiogra-
phy (DSA).
Eight patients with occlusive arterial diseases of the lower extremities underwent 16 CEMRA scans. The sex ratio was 6: 2 (male: female) and their ages ranged from 44 to 71 (average, 63) years. Patients were scheduled to be examined by conventional DSA, but before this, lowdose CEMRA was carried out with the patients complete agreement of the patients. After CEMRA, conventional DSA was performed within one week.
For CEMRA, a 1.5 Tesla MR scanner (Magnetom Vision Plus, Siemens, Erlangen, Germany) was used. The pulse sequence was three-dimensional turbo fast low angle shot (turbo -FLASH). The scanning parameters were 4.0 msec repetition time, 1.6 msec echo time, 30 degree flip angle, a matrix of 155 255 and a slice thickness of 1.5 mm. Acquisition time ranged from 17 to 20 seconds according to the size of the field of view. The RF coil used was the whole body rather than surface type.
The examination of a patient involved the use of two stations, and this allowed coverage from the common iliac to the distal tibial artery. The acquisition planes of both stations were coronal, with slight inclinations along the courses of the superficial femoral and tibial arteries. After measuring arterial peak enhancement time and calculating the scan delay time, preliminary non-enhanced mask images were acquired at both the proximal and distal stations. The mask image for the second station was acquired by scanning with the same sequencing after stepping the table to the pre-selected coordinates. Subsequently, contrast-enhanced acquisitions were obtained with as long an intermission as possible between the two stations. At each station, to avoid missing the arterial phase acquisition, three-phase images were acquired. The first phase was started at the calculated scan delay time and the second was acquired immediately afterwards; these two phases were expected to cover the early and late arterial phases. So as to include the later venous phase, the third-phase scan was obtained 50 seconds after completion of the second phase.
The calculation of scan delay time was achieved by monitoring the time-intensity curve. After 2ml of contrast medium (Omniscan, Nycomed Imaging AS, Oslo, Norway) was injected, repeated two-dimensional FLASH scans with 1-second intervals continued for 60 seconds. The injection rate of the contrast medium (3 ml / sec) was controlled using an automated power injector (Medrad, Indianola, Pa., U.S.A.). After injection of the test-dose of contrast medium, and to push the contrast bolus, 20 ml of normal saline was infused at the same rate. The acquisition plane was single and axial, and located at the level of the lower pole of the right kidney. During the scanning procedure, the patient s breathing was not restricted. The region of interest (ROI) was drawn at the infrarenal abdominal aorta and a time-intensity curve was plotted. After measuring the arterial peak enhancement time from the time-intensity curve, the scan delay time was calculated using the formula below.
d =Scan delay time, p =Arterial peak enhancement time, a =Acquisition time of main scan for MR angiography Contrast-enhanced scanning was performed using the same protocol as for unenhanced scanning, which was used as a mask image during digital subtraction, except for the contrast enhancement and station priorities. To reduce table movement, acquisitions of the contrast-enhanced stations were performed in reverse order of unenhanced acquisitions. The dose of contrast medium used was 0.075 mmol / kg at each station and the total dose per patient amounted to 0.15 mmol / kg. Bolus injection of the main dose of contrast medium was carried out using the same method as for test-dose injection. To reduce venous and soft tissue enhancement by the previous contrast injection, the period between the former and latter stations was intentionally delayed by approximately 15 minutes.
After the reconstruction of raw data, and in order to eliminate the background signal, each mask image was subtracted from the corresponding station of the contrast-enhanced image. The venous phase image was obtained by subtracting the first arterial phase from the third phase, to remove the arterial signal. Subsequently, maximum intensity projection was performed, and projections were made along ten different planes, from 0 to 180 degrees, with increments of 18 degrees.
DSA was performed by fluoroscopy (Advantx, GE a 4 Medical Systems, Milwaukee, Wis., U.S.A.), radiographic projection being made in the anteroposterior direction. After puncturing the right common femoral artery, a 5-F visceral catheter (Cook, Bloomington, Ind., U.S.A.) was introduced, and using the Seldinger technique, was moved up to the aortic bifurcation. Iodinated contrast medium (Ultravist 370, Schering, Berlin, Germany) was then injected at a rate of 9 mL / sec using a power injector (Angiomat 6000, Liebel-Flarsheim Co, Cincinnati, Ohio, U.S.A.). The total injected amount was 80 100 ml. Both lower extremities from the common iliac to the distal tibial arteries were examined simultaneously by manual stepping of the table to chase the bolus of contrast medium. Four or five steps were required to cover the whole of the lower extremity, and during each step, two to four images were acquired.
Arteries of the lower extremity were divided into five groups, in order of size (Table 1) . Group I included the largest arteries of the lower extremities, such as the common iliac, whereas group V contained the smallest arteries, such as the circumflex iliac. A blind method was used to arrive at an interpretation of both CEMRA and DSA, with an interval of at least one-week between the two, the interpretation being concluded by agreement between two radiologists. The arteries depicted by both examinations were compared in three ways.
Firstly, the arterial detectability of low-dose CEMRA was assessed. Visualized arteries in each arterial group were counted, and the numbers summated for both CEMRA and DSA images (Table 1) . Based on the result of DSA, true and false depictions were counted in each group and a cross-table analysis was performed.
Secondly, the ability of low-dose CEMRA to estimate the severity of stenosis was examined. All stenotic lesions visualized by CEMRA were graded using a fivepoint method: normal, grade 0; mildly stenotic (50%), grade 1; moderately stenotic (51% 75%), grade 2; severely stenotic (76% 99%), grade 3; and occluded or not visualized, grade 4 (14) . Using bi-directional correlative analysis, this result was then compared with the findings of DSA. The arteries included in group V were too small to allow the objective grading of stenosis, and accordingly, this group was excluded from this comparison.
Thirdly, the detectability of significant stenosis (more than 50% of a vessel s diameter) by low-dose CEMRA was assessed. The number of significantly stenotic lesions was counted in each angiogram, and true and the false depictions by CEMRA were analyzed and correlated with the results of DSA. The arterial detectability of low-dose contrast-enhanced MR angiography was evaluated on the basis of conventional digital subtraction angiography. In whole groups, the positive predictive value (PPV) and specificity (Sp) were high which is in contrast to its low sensitivity (Sn) and negative predictive value (NPV). Although PPV and Sp were high in all groups, Sn and NPV showed an abrupt decrease in groups IV and II, respectively. The accuracies (Acc) in groups I, II, and III, were high (over 90%), however, in the other groups the accuracy decreased to less than 70%.
A total count of arterial groups in all patients was conducted, with 223 arteries depicted by CEMRA, and 319 by conventional DSA. Overall arterial depiction by CEMRA had a relatively high specificity (Sp, 99%) and positive predictive value (PPV, 99.6%), in contrast to its relatively low sensitivity (Sn, 70%) and negative predictive value (NPV, 47%). Although Sn and accuracy (Acc) were greater than 90% throughout group III, both decreased dramatically in groups IV and V, and in group II, NPV was also sharply reduced. Sp and PPV, however, maintained high values in all groups (Table 2, Figure  1) . Fisher s exact test. Showed that the results were statistically significant (p<0.01). In summary all arteries visualized by low-dose CEMRA were also visualized by D-SA, though the converse was not true (Fig. 2) .
CEMRA detected 60 stenotic lesions. A comparison of stenosis grading scores awarded to CEMRA and DSA images demonstrated an overall correlation coefficient of 0.35*. In groups I and II, the correlation coefficient was 0.63*, but in the other groups the coefficient decreased markedly, resulting in no statistical significance (Fig. 3) . By plotting the grading scores, the tendency of CEMRA to overestimate became apparent, and despite the lack of statistical significance, this was more obvious in groups III and IV (Fig. 4) . The grade of stenosis awarded by the two methods to arteries larger than the tibioperoneal trunk correlated well, although DSA gave a grading score about 0.6 times lower than that of CEM-RA (Fig. 5) .
Among the total of 60 stenotic lesions depicted by CEMRA, 47 were regarded as having significant stenosis. According to the findings of DSA, however, significant stenosis was confirmed in only 25. Overall Sn and NPV reached 100%, whereas Sp, PPV, and Acc were 37%, 53%, and 63%, respectively. Although PPV and Acc showed relatively high values of over 70% in groups I and II, in the other groups these values decreased to below 50% (Table 3, Figure 6 ). CEMRA tended to overestimate in this comparison, too. The PPV of significant stenosis decreased extensively in arteries smaller than the proximal tibial, though it was better than 70% in larger arteries. Where low-dose CEMRA Comparison of arterial detectability. In low-dose contrast-enhanced MR angiography (A), 34 arteries were detected in the whole of the lower extremities, whereas 43 arteries were found in conventional digital subtraction angiography (B). The sensitivity and specificity were 79% and 100%, respectively. All arteries depicted in MR angiography (A), were also observed in conventional angiography (B). Although there was false negative depiction, no false positive angiography was observed in MR angiography. Two stations were united in (A), and five stations were united in (B).
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did not detect significant stenosis, this suggested, correctly, that the condition would not be detected by DSA, either. This was true of all arterial groups visualized by CEMRA.
Since subjects were examined by two-station MR angiography, the contrast dose per station was set to 0.075 mmol / kg in order to limit the total quantity administered per patient to 0.15 mmol / kg. This low dose became a practical possibility because of the bolus injection of contrast medium and the scan timing calculation performed for each subject. In previous reports dealing with MR aortography (5, 8) , doses of gadolinium chelate as large as 60 mL have been used to ensure adequate arterial enhancement. Other reports, however, have claimed that 0.1 mmol / kg is sufficient to acquire adequate artery-to-background contrast, if the central kspace can be filled at the critical time and bolus injection of contrast medium can be performed (12, 13) . According to the latter suggestion, we used a contrast medium level of 0.1 mmol / kg per station. At a later stage of this work the amount of contrast medium was reduced further to 0.075 mmol/Kg, at which level satisfactory CEMRAs of the lower extremities were acquired. Although 2-D TOF CEMRA using 0.05 mmol / Kg contrast medium has been shown to be superior to the conventional 2-D TOF technique (10), we adopted 3-D turbo-FLASH and the result was compared with conventional digital subtraction angiography.
Since the variables for the scan delay time calculation were arterial peak enhancement time and acquisition time, information about the time of venous enhancement or optimum bolus length was not obtained. Thus, the acquisition time was set at the minimum, in spite of the lower resolution. A surface coil was not used in this study because it was not able two stations to cover the whole length of the lower extremities, and this provides another possible way of improving the quality of CEM-RA. In the case of short coverage, the surface coil could be used to increase the signal-to-noise ratio between the arteries and the background.
The timing examination was performed at the infrarenal abdominal aorta because the respiratory motion was less severe and enhancement was strong in this area. Respiratory motion produced a radial pattern centered in the area of the aorta, and no marked shifting of aorta beyond the ROI boundary occurred. In the literature, several methods of determining scan delay time have been suggested (7, 5, 13, 16) , the most commonly used having been suggested by Prince (5) . This formula (arterial peak enhancement time+half of contrast-injection duration -half of acquisition time) allowed a specific scan delay time to be calculated for each patient. In this method, in order to match the center of the main bolus to the center of the k-space, half the contrast-injection duration was added. This procedure is based on the premise that the length of the bolus is equal to the duration of injection, but for the main bolus, this is not in fact the case: the time-intensity curve produced by testbolus injection showed that the bolus length was up to 16 times greater (13) . In this work, this kind of mismatch was also generally observed, and because of these discrepancies we excluded the injection duration parameter and produced our own protocol.
The ability of low-dose CEMRA to detect arteries was compared to that of conventional DSA, assuming that D-SA displays arteries perfectly, and the number depicted by DSA was 1.8 times greater than that detected by CEMRA. The practical difference between the two methods is best demonstrated by the number of false depictions by CEMRA, almost all of which were false negatives. Only one depiction was a false positive; CEMRA detected an artery not revealed by DSA. This   Fig. 3 . The correlation of stenosis-grading scores between lowdose contrast-enhanced MR angiography and conventional digital subtraction angiography revealed statistical significance in group I, II and in global groups. In group III and IV, there were no significant correlations.
was because the anterior tibial artery was accidentally subtracted during DSA s computerized image assembly, a fact attributed to motion during exposure. This artery was identified by Doppler ultrasonography; the same artery identified by CEMRA was not imaginary, and there was, therefore, no case of a false positive detection of an artery by CEMRA. All false values were caused by omissions. Because of these facts, we are convinced that the PPV of low-dose CEMRA was 100%. Thus, if arteries are detected by CEMRA, complete arterial obstruction can be excluded. In arteries greater than the superficial femoral artery (group I), the NPV of CEMRA was also high enough to predict the absence of the artery. Due to the high Sp and PPV of low-dose CEMRA, for the detection of arteries, this method could be used as a screening test for the purpose of arterial identification. For these in group I, the method could also be used to identify obstruction.
It is apparent that the depiction of an artery by CEM-RA excludes the possibility of complete arterial obstruction, though the severity of stenosis can not be estimated on this basis. Measurement of the severity of stenosis by low-dose CEMRA was analyzed in order to augment the technique in some way and allow low-dose CEMRA to be used for the diagnostic study of arterial stenosis. As can be seen from the results, it is clear that low-dose CEMRA overestimated stenosis, a tendency which is understood to be the main drawback of this modality (1) . The statistically significant correlation in groups I and II was, however, noteworthy, and armed with an understanding of the degree of overestimation by CEM-RA, the severity of stenotic lesions in arteries larger than the tibioperoneal trunk could be estimated. In arteries smaller than this, the tendency of CEMRA to overesti-914 Fig. 4 . The grading scores of stenotic lesions were plotted by group. The whole-data plotting regardless of groups (A) revealed that most plots were located in the MR angiography side showing a deviated trend-line (solid line) towards the X-axis. This result implies the overestimating tendency of contrast-enhanced MR angiography. This tendency was exaggerated in group III and IV (D, E). Actually there was no plot on the conventional angiography side in group II, III, and IV (C-E). In groups I and II, which showed a statistically significant correlation, the fitting equation disclosed a stenosis-grading score for conventional angiography a factor of 0.6 times lower than that of MR angiography. The number of points on the graph (A) is not equal to the total number of recorded stenosis (n=60), because some of the points overlap.
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mate was very large, and this led to the conclusion that the differences noted between CEMRA and DSA were not statistically significant. Prediction of the severity of stenosis in smaller arteries was thus thought inadvisable.
In the literature, hemodynamically significant stenosis is defined as the narrowing of a vascular diameter by more than 50% and a decrease of cross sectional area to less than 25% (17) . From the viewpoint of clinicians, the concept of significant stenosis is more important than its grading. Thus, the detectability of significant stenosis would be a more practical criterion to apply to the evaluation of a stenotic lesion. Several reports have been published in which more than the standard dose of contrast medium has been used, and these have verified the sensitivity and specificity of CEMRA in arteries of the lower extremity as 100% and 69% (18), 92% and 88% (1), and 100% and 97% (19) . In this study, the overall sensitivity and specificity were 100% and 37%, a relatively low specificity compared to that of previous reports. In group I arteries, however, which were the subject of these earlier reports, specificity was 70%. In 915 Fig. 6 . In low-dose contrast-enhanced MR angiography, the detectability of significant stenosis, more than 50% in diameter, disclosed a sensitivity (Sn) and negative predictive value (NPV) of 100% in all groups. Whereas, specificity (Sp), positive predictive value (PPV), and accuracy (Acc) showed an abrupt decrease in groups III and IV. The whole data group revealed high Sn and NPV, although the other parameters were relative low. Fig. 5 . The overestimating tendency of low-dose contrast-enhanced MR angiography. CEMRA (A) shows grade III stenosis at distal portion of right superficial femoral artery, whereas DSA (B) shows grade I or II stenosis at the same point (arrows). terms of this comparison, it is apparent that there is no marked difference in the detectability of significant stenosis between the low-dose CEMRA method and CEMRA using higher doses of contrast medium. Because of the tendency of CEMRA to overestimate, its accuracy is not as high as its sensitivity or its negative predictive value. This latter also reached 100% in all arterial groups, showing the usefulness of low-dose CEM-RA for the screening of significant stenosis, which could thus be excluded if not revealed by low-dose CEMRA. In this study, DSA, due to its clear depiction of arteries, was regarded as the standard. By comparison, the pitfalls of CEMRA are thought to arise because of venous enhancement, the overestimation of stenosis, and motion induced subtraction failure. The tendency to overestimate is believed to be due to spin dephasing, caused by turbulent flow, that cannot be compensated for by using gadolinium chelate (1) . In Korea, the cost of CEMRA is another disadvantage, because of a lack of support by the medical insurance companies. Its ability to depict subtle eccentric plaque, however, which can not be detected by DSA in an en face projection, is regarded as a value of CEMRA (5, 7, 20, 21) . The evaluation of tortuous arteries was also reported to be easier by CEMRA than by DSA (5, 14, 20, 21) . The other advantages which CEMRA has over DSA are that ionizing radiation and iodine contrast media are not required, it has a large field of view, multiplanar reprojection, is less invasive and easier to apply, and is safer in terms of outpatient examination (1).
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Low-dosage CEMRA has a high positive predictive value in arterial detection and a high negative predictive value of significant arterial stenosis in all arterial groups of the lower extremities. A statistically significant correlation with stenosis grading was noted in greater arteries, although its tendency to overestimate persisted. We thus conclude that the use of low-dose contrast-enhanced MR angiography can exclude the possibility of significant stenosis or complete obstruction in arteries of the lower extremities, and can grade stenosis in arteries greater than the tibioperoneal trunk. Due consideration must be given, however, to the tendency of CEMRA to overestimate.
